Ryr2tm2.1Maya
Targeted Allele Detail
|
Symbol: |
Ryr2tm2.1Maya |
Name: |
ryanodine receptor 2, cardiac; targeted mutation 2.1, Masafumi Yano |
MGI ID: |
MGI:5432932 |
Synonyms: |
RyR2S2246L |
Gene: |
Ryr2 Location: Chr13:11567988-12121831 bp, - strand Genetic Position: Chr13, 4.38 cM, cytoband A1-A2
|
Alliance: |
Ryr2tm2.1Maya page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:186291
|
Parent Cell Line: |
CMTI-2 (ES Cell)
|
Strain of Origin: |
C57BL/6J
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: Exon 43 was replaced with one in which nucleotide substitutions result in the amino acid substitution of serine with leucine at position 2245 in the encoded peptide (p.S2245L), mimicking a mutation found in some catecholaminergic polymorphic ventricular tachycardia patients. The floxed neomycin resistance gene cassette that was inserted into intron 43 was removed by cre-mediated recombination.
(J:186291)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Ryr2 Mutation: |
325 strains or lines available
|
|
Original: |
J:186291 Suetomi T, et al., Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca(2)(+)release leading to catecholaminergic polymorphic ventricular tachycardia. Circulation. 2011 Aug 9;124(6):682-94 |
All: |
1 reference(s) |
|